Health and Financial Benefits of Needle and Syringe Programs in Yunnan, China

publication Evidence: high

Author Information

Author(s): Zhang Lei, Yap Lorraine, Xun Zhuang, Wu Zunyou, Wilson David P

Primary Institution: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales

What are the population benefits and cost-effectiveness of needle and syringe programs (NSPs) in reducing HIV infections in Yunnan, China?

NSPs are cost-effective and cost-saving in Yunnan, leading to significant health benefits and financial savings.

NSPs have averted approximately 5,200-7,500 HIV infections since 2002.
The total spending on NSPs from 2002 to 2008 was $1.04 million, resulting in estimated cost savings of $1.38-$1.97 million.
NSPs led to gains of 1,300-1,900 disability-adjusted life years (DALYs).
The investment in NSPs is projected to yield even greater savings over the lifetime of the current population.

Needle and syringe programs help people avoid getting sick from HIV and save money for the government by preventing infections.

A mathematical transmission model was developed to estimate infections averted and conduct a health economics analysis.

Potential bias due to reliance on data from various sources and assumptions made in the model.

The study may underestimate the cost-effectiveness due to not including secondary impacts of NSPs and variations in treatment costs across provinces.

The majority of injecting drug users (IDUs) in Yunnan are young, with approximately 80% in their 20s and 30s.

Access the complete publication on the publisher's website